Q3 2023 DURECT Corp Earnings Call Transcript
Good afternoon, everyone, and welcome to the DURECT Corporation third-quarter earnings conference call. All participants will be in a listen-only mode. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. (Operator Instructions) Please also note today's event is being recorded. And at this time, I'd like to turn the floor over to Tim Papp, Chief Financial Officer. Please go ahead.
Thank you. Good afternoon and welcome to DURECT Corporation's third-quarter 2023 earnings conference call. Before we begin, I would like to remind everyone of our forward-looking statements. During the course of this call, we will make forward-looking statements regarding the results and clinical data from the AHFIRM trial, development plans for larsucosterol, expected product benefits, market potential, regulatory plans, potential regulatory approval, and the company's financial projections.
These forward-looking statements involve risks and uncertainties that can cause actual results to differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |